Cross-fund · 5 holders
RXRX
RECURSION PHARMACEUTICALS IN
CUSIP 75629V104
5
Tracked holders
$341.2M
Aggregate value
95,472,001
Shares
5
Active funds
Funds holding RXRX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $193.0M | — | +7,407,606 | +18.6% |
| BlackRock | Institutional | Q1 2026 | $132.6M | — | +4,325,527 | +11.1% |
| Millennium | Multi-Strategy | Q1 2026 | $8.0M | — | +1,116,438 | +74.6% |
| Citadel | Multi-Strategy | Q1 2026 | $7.5M | — | -5,741,040 | -70.2% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $142,141 | — | -607,911 | -92.9% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.